The strongest growth outlook in over two years is in sight! The US stock market's medical device sector still needs to endure another sluggish earnings season.
智通财经2026/10/09 12:21Zhihu Finance APP noted that medical device companies are expected to go through another sluggish earnings season before entering 2027 with the strongest growth outlook in more than two years—following a challenging period for the industry marked by policy uncertainty, cyberattacks, and product recalls.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
US Stocks Movement: Moderna surges on October 9, included in Nasdaq 100 + Cancer Vaccine
US Stock Movement: Twist Bioscience surged on October 9 as price target was raised and trading was launched
【US Stock Movements】Grail surged on October 9: Regulatory support, Galleri data, and growth in testing
